13F
← All fund report cards

SG Capital Management LLC

13F equity value
$1.2B
Positions
79
Top 10 concentration
37.5%
Quarters / total new picks
32 / 628
13F equity value over time
$0M$608M$1B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 37.5% of quarters (excess t = 0.27, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.3%
t-stat
0.27
Quarterly win rate
38%
Annualized excess
-2.0%
$1 → follow vs universe
$1.80 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.03520180630: follow 0.91920180930: follow 0.95120181231: follow 0.94220190331: follow 0.92020190630: follow 0.96720190930: follow 1.04320191231: follow 0.76920200331: follow 0.87920200630: follow 0.92420200930: follow 1.07820201231: follow 1.19820210331: follow 1.15020210630: follow 1.28620210930: follow 1.19720211231: follow 0.99520220331: follow 0.98420220630: follow 1.02020220930: follow 1.07620221231: follow 0.94720230331: follow 1.06320230630: follow 1.03220230930: follow 1.21220231231: follow 1.28220240331: follow 1.28320240630: follow 1.39820240930: follow 1.38220241231: follow 1.27020250331: follow 1.38020250630: follow 1.31920250930: follow 1.65420251231: follow 1.801 0.71 1.48 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 79 · 2026 Q1

Ticker Value Weight QoQ
TECH $64M
5.2%
ADD
WSO $59M
4.8%
NEW
ONTO $47M
3.9%
ADD
WEX $46M
3.8%
NEW
JBL $46M
3.8%
NEW
ARW $41M
3.3%
NEW
LKQ $40M
3.3%
NEW
VCEL $39M
3.2%
NEW
CHWY $38M
3.1%
NEW
GPC $36M
3.0%
NEW
ENVA $36M
2.9%
ADD
RVTY $31M
2.5%
NEW
SMG $30M
2.4%
ADD
AIT $29M
2.4%
NEW
GXO $29M
2.4%
ADD
DCI $25M
2.0%
NEW
HLIO $24M
2.0%
ADD
CXT $24M
2.0%
ADD
AWI $24M
1.9%
NEW
CVSA $23M
1.9%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.